Knihu momentálně nemáme skladem

Parametry
- Počet stran
- 236 stránek
- Čas čtení
- 9 hodin
Více o knize
The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.
Nákup knihy
Diagnosis and Treatment of Parkinsons Disease State of the Art, Horst Przuntek, Thomas Müller
- Jazyk
- Rok vydání
- 1999
- product-detail.submit-box.info.binding
- (měkká)
Jakmile ji vyčmucháme, pošleme vám e-mail.
Doručení
Platební metody
Navrhnout úpravu
- Titul
- Diagnosis and Treatment of Parkinsons Disease State of the Art
- Jazyk
- anglicky
- Autoři
- Horst Przuntek, Thomas Müller
- Vydavatel
- Springer Vienna
- Rok vydání
- 1999
- Vazba
- měkká
- Počet stran
- 236
- ISBN13
- 9783211832752
- Anotace
- The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.